Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × tocilizumab × Clear all

Phase

Phase 1 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Arthritis, Rheumatoid 2 Stroke 1 Spondylitis, Ankylosing 1 Pulmonary Disease, Chronic Obstructive 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Kidney Failure, Chronic 1 Diabetes Mellitus 1 Coronary Artery Disease 1 COVID-19 1

Interventions

Cyclophosphamide 51 Vincristine 49 Doxorubicin 47 Rituximab 38 Prednisone 38 Radiotherapy 31 Etoposide 31 Cytarabine 22 Filgrastim 19 Methotrexate 18 Bleomycin 17 Dexamethasone 15 Carmustine 12 Vinblastine 11 VAP-cyclo protocol 11 Prednisolone 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Mitoxantrone 9 Mercaptopurine 9 Leucovorin 8 Dacarbazine 8 Lenalidomide 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 ibrutinib 6 Procarbazine 6 Gemcitabine 6 Epoetin Alfa 6 Daunorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084936 2026-03-03

GLOBRYTE

Hoffmann-La Roche

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡